NasdaqGS - Delayed Quote USD
Inhibrx Biosciences, Inc. (INBX)
12.86
+0.32
+(2.55%)
At close: May 23 at 4:00:01 PM EDT
13.50
+0.64
+(4.98%)
After hours: May 23 at 4:15:41 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
Total Assets
180,767
307,893
16,645
Total Liabilities Net Minority Interest
47,183
264,390
23,945
Total Equity Gross Minority Interest
133,584
43,503
-7,300
Total Capitalization
133,584
250,471
-7,300
Common Stock Equity
133,584
43,503
-7,300
Capital Lease Obligations
8,048
3,173
5,033
Net Tangible Assets
133,584
43,503
-7,300
Working Capital
119,668
239,046
-14,509
Invested Capital
133,584
250,471
-7,300
Tangible Book Value
133,584
43,503
-7,300
Total Debt
8,048
210,141
5,033
Share Issued
14,475.90
14,241.18
14,241.18
Ordinary Shares Number
14,475.90
14,241.18
14,241.18
12/31/2022 - 6/4/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HOPHF Hemogenyx Pharmaceuticals Plc
0.0400
0.00%
IMVT Immunovant, Inc.
14.46
-0.69%
VCEL Vericel Corporation
40.92
-1.11%
KYMR Kymera Therapeutics, Inc.
29.49
-2.25%
ROIV Roivant Sciences Ltd.
10.87
-0.64%
ALNEV.PA Neovacs S.A.
0.0050
+4.17%
ZBIO Zenas BioPharma, Inc.
11.43
-0.17%
PBYI Puma Biotechnology, Inc.
3.2350
-0.46%
ASMB Assembly Biosciences, Inc.
13.52
-0.29%
ENTA Enanta Pharmaceuticals, Inc.
5.81
+1.04%